Arthur G. Pratt

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications

Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocol.

Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocol.

Journal: BMJ open
Published: March 03, 2026

Interobserver variability in synovial tissue biopsy markers in Rheumatoid Arthritis: Results from OMERACT special interest group on synovial tissue biopsy.

Interobserver variability in synovial tissue biopsy markers in Rheumatoid Arthritis: Results from OMERACT special interest group on synovial tissue biopsy.

Journal: Seminars in arthritis and rheumatism
Published: February 06, 2026

Referral pathways and duration of care for musculoskeletal complaints across Europe: an analysis of primary and secondary care.

Referral pathways and duration of care for musculoskeletal complaints across Europe: an analysis of primary and secondary care.

Journal: Annals of the rheumatic diseases
Published: January 26, 2026

Rheumatoid arthritis and osteoarthritis patients demonstrate comparable rates of major adverse cardiovascular events: a single-centre retrospective cohort study.

Rheumatoid arthritis and osteoarthritis patients demonstrate comparable rates of major adverse cardiovascular events: a single-centre retrospective cohort study.

Journal: Rheumatology advances in practice
Published: December 07, 2025

Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial.

Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial.

Journal: The Lancet. Rheumatology
Published: November 11, 2025

Autoreactivity Versus Autoimmunity: Characteristics of Autoantigen-Specific CD4 T Cells in Rheumatoid Arthritis and Health.

Autoreactivity Versus Autoimmunity: Characteristics of Autoantigen-Specific CD4 T Cells in Rheumatoid Arthritis and Health.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 06, 2025

Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis.

Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis.

Journal: RMD open
Published: September 22, 2025

Methods for Prioritizing Causal Genes in Molecular Studies of Human Disease: The State of the Art.

Methods for Prioritizing Causal Genes in Molecular Studies of Human Disease: The State of the Art.

Journal: Genetic epidemiology
Published: June 26, 2025

Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single-arm, experimental medicine study.

Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single-arm, experimental medicine study.

Journal: The Lancet. Rheumatology
Published: April 14, 2025

Immune checkpoint inhibitor-induced inflammatory arthritis.

Immune checkpoint inhibitor-induced inflammatory arthritis.

Journal: Clinical medicine (London, England)
Published: April 14, 2025

Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study.

Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study.

Journal: BMJ open
Published: April 09, 2025

PEPITEM Regulates the Synovial Microenvironment During Immune-Mediated Inflammatory Arthritis to Limit Disease.

PEPITEM Regulates the Synovial Microenvironment During Immune-Mediated Inflammatory Arthritis to Limit Disease.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 19, 2025
Showing 1-12 of 97

Last Updated: 09/26/2026